Literature DB >> 20847660

Survival after transplantation of corneas from a rabies-infected donor.

Jan M Vetter1, Lars Frisch, Christian Drosten, R Stefan Ross, Michael Roggendorf, Bernd Wolters, Thomas Müller, H Burkhard Dick, Norbert Pfeiffer.   

Abstract

PURPOSE: To examine the tissue samples of 2 corneal recipients from a rabies-infected donor for the presence of rabies to explain their survival.
METHODS: Interventional case series with a review of the literature. The explanted corneal donor buttons were examined via nested reverse transcriptase polymerase chain reaction. The patients were followed up ophthalmologically and neurologically. Antirabies antibodies were measured in blood samples, and skin biopsies were examined by direct fluorescent antibody staining.
RESULTS: Two patients received corneas from the same multiorgan donor. Six weeks after transplantation, 3 of the donor's organ recipients became symptomatic and rabies virus was confirmed in tissue from the donor's central nervous system. Immediately, both the corneal recipients underwent active and passive postexposure treatment. The corneal buttons were replaced. Examination of the explanted donor corneas, skin biopsies, and serum and saliva samples showed no signs of rabies infection. The 2 corneal recipients were followed up at our hospital and, to date, are without symptoms of infection.
CONCLUSIONS: Transmission of the potentially deadly rabies virus by corneal transplantation has been described previously. To our knowledge, this is the first report in which no rabies virus transmission occurred without immediate postexposure treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20847660     DOI: 10.1097/ICO.0b013e3181e4572a

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

Review 1.  Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis.

Authors:  Anita Mahadevan; M S Suja; Reeta S Mani; Susarala K Shankar
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

2.  Clinical management and humoral immune responses to rabies post-exposure prophylaxis among three patients who received solid organs from a donor with rabies.

Authors:  N M Vora; L A Orciari; M Niezgoda; G Selvaggi; V Stosor; G M Lyon; R M Wallace; J Gabel; D R Stanek; P Jenkins; M Shiferaw; P Yager; F Jackson; C A Hanlon; I Damon; J D Blanton; S Recuenco; R Franka
Journal:  Transpl Infect Dis       Date:  2015-05-19       Impact factor: 2.228

3.  Raccoon rabies virus variant transmission through solid organ transplantation.

Authors:  Neil M Vora; Sridhar V Basavaraju; Katherine A Feldman; Christopher D Paddock; Lillian Orciari; Steven Gitterman; Stephanie Griese; Ryan M Wallace; Maria Said; Dianna M Blau; Gennaro Selvaggi; Andres Velasco-Villa; Jana Ritter; Pamela Yager; Agnes Kresch; Mike Niezgoda; Jesse Blanton; Valentina Stosor; Edward M Falta; G Marshall Lyon; Teresa Zembower; Natalia Kuzmina; Prashant K Rohatgi; Sergio Recuenco; Sherif Zaki; Inger Damon; Richard Franka; Matthew J Kuehnert
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

4.  Validation of Spiked Postmortem Blood Samples from Cornea Donors on the Abbott ARCHITECT and m2000 Systems for Viral Infections.

Authors:  Ingo Schmack; Seda Ballikaya; Brigitte Erber; Irina Voehringer; Ulrich Burkhardt; Gerd U Auffarth; Paul Schnitzler
Journal:  Transfus Med Hemother       Date:  2019-09-24       Impact factor: 3.747

5.  Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies.

Authors:  Lara Schöler; Vu Thuy Khanh Le-Trilling; Ulf Dittmer; Melanie Fiedler; Mirko Trilling
Journal:  PLoS Negl Trop Dis       Date:  2022-05-10

6.  Probable Rabies Virus Transmission through Organ Transplantation, China, 2015.

Authors:  Hang Zhou; Wuyang Zhu; Jun Zeng; Jianfeng He; Kai Liu; Yu Li; Shuwu Zhou; Di Mu; Kechun Zhang; Pengcheng Yu; Zhijian Li; Meng Zhang; Xueqiong Chen; Chun Guo; Hongjie Yu
Journal:  Emerg Infect Dis       Date:  2016-08-15       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.